Leppänen Anne, Stowell Sean, Blixt Ola, Cummings Richard D
Department of Biochemistry and Molecular Biology, Oklahoma Center for Medical Glycobiology, University of Oklahoma Health Sciences Center, 975 N. E 10th St., Oklahoma City, OK 73104, USA.
J Biol Chem. 2005 Feb 18;280(7):5549-62. doi: 10.1074/jbc.M412019200. Epub 2004 Nov 19.
Galectin-1 is a member of the galectin family of glycan-binding proteins and occurs as an approximately 29.5-kDa noncovalent homodimer (dGal-1) that is widely expressed in many tissues. Here, we report that human recombinant dGal-1 bound preferentially and with high affinity (apparent K(d) approximately 2-4 microM) to immobilized extended glycans containing terminal N-acetyllactosamine (LN; Galbeta1-4GlcNAc) sequences on poly-N-acetyllactosamine (PL; (-3Galbeta1-4GlcNAcbeta1-)(n)) sequences, complex-type biantennary N-glycans, or novel chitin-derived glycans modified to contain terminal LN. Although terminal Gal residues are important for dGal-1 recognition, dGal-1 bound similarly to alpha3-sialylated and alpha2-fucosylated terminal LN, but not to alpha6-sialylated and alpha3-fucosylated terminal LN. The binding specificity of human recombinant dGal-1 was similar to that observed with purified bovine heart-derived dGal-1. Unexpectedly, dGal-1 bound free ligands in solution with relatively low affinity and displayed no preference for extended glycans, indicating that dGal-1 preferentially recognizes extended glycans only when they are surface-bound, such as found on cell surfaces. Human dGal-1 also bound to both native and desialylated human promyelocytic HL-60 cells with similar affinity as observed for immobilized long chain PL. Binding to these cells was reduced upon treatment with endo-beta-galactosidase, which cleaves PL sequences, indicating that cell-surface PLs are ligands. To test the role of dimerization in dGal-1 binding, we examined the binding of a mutated form of dGal-1 that weakly dimerizes (monomeric Gal-1 (mGal-1)) and a covalently dimerized (chemically cross-linked) form of mGal-1 (cd-mGal-1). dGal-1 and cd-mGal-1 had similar affinities that were both approximately 3.5-fold higher for immobilized PL than observed for mGal-1, suggesting that dGal-1 acts as a dimer to cross-link terminal LN units on immobilized PL. These results indicate that dGal-1 functions as a dimer to recognize LN units on extended PLs on cell surfaces.
半乳糖凝集素-1是聚糖结合蛋白半乳糖凝集素家族的成员,以一种约29.5 kDa的非共价同源二聚体(dGal-1)形式存在,在许多组织中广泛表达。在此,我们报告人重组dGal-1优先且以高亲和力(表观K(d)约为2 - 4 microM)结合固定化的含有末端N-乙酰乳糖胺(LN;Galβ1-4GlcNAc)序列的延伸聚糖,这些聚糖存在于聚-N-乙酰乳糖胺(PL;(-3Galβ1-4GlcNAcβ1-)(n))序列、复合型双天线N-聚糖或经修饰含有末端LN的新型几丁质衍生聚糖上。虽然末端Gal残基对dGal-1识别很重要,但dGal-1与α3-唾液酸化和α2-岩藻糖基化的末端LN结合相似,但不与α6-唾液酸化和α3-岩藻糖基化的末端LN结合。人重组dGal-1的结合特异性与从牛心脏纯化得到并观察到的dGal-1相似。出乎意料的是,dGal-1与溶液中的游离配体结合亲和力相对较低,且对延伸聚糖没有偏好,这表明dGal-1仅在延伸聚糖表面结合时,如在细胞表面发现的那样,才优先识别它们。人dGal-1还以与固定化长链PL相似的亲和力结合天然和去唾液酸化的人早幼粒细胞HL-60细胞。用内切β-半乳糖苷酶处理后,与这些细胞的结合减少,内切β-半乳糖苷酶可切割PL序列,表明细胞表面的PLs是配体。为了测试二聚化在dGal-1结合中的作用,我们检测了一种弱二聚化的dGal-1突变形式(单体Gal-1(mGal-1))和一种mGal-1的共价二聚化(化学交联)形式(cd-mGal-1)的结合情况。dGal-1和cd-mGal-1具有相似的亲和力,两者对固定化PL的亲和力均比对mGal-1观察到的亲和力高约3.5倍,这表明dGal-1作为二聚体交联固定化PL上的末端LN单元。这些结果表明dGal-1作为二聚体识别细胞表面延伸PLs上的LN单元。